What is HPC Biosciences Ltd (535217) share price return in the past 10 years?

HPC Biosciences Ltd share price has declined -4.6% annually (CAGR) over the past ten years.

What is the share price of HPC Biosciences Ltd (535217)?

Company share prices are keep on changing according to the market conditions. The current trading price of HPC Biosciences Ltd (535217) on 29-Jul-2024 16:01:00 at 16:01 is 25.68.

What is the P/E ratio of HPC Biosciences?

The latest standalone P/E ratio of HPC Biosciences as of 29-Jul-2024 is 0.00.

What is the P/B ratio of HPC Biosciences Ltd (535217)?

The latest standalone P/B ratio of HPC Biosciences Ltd (535217) as of 29-Jul-2024 is 12.48.

What is the 52-week high and low of HPC Biosciences Ltd (535217)?

The 52-week high of HPC Biosciences Ltd (535217) is Rs. 25.68 and the 52-week low is Rs. 25.68.

HPC Biosciences Ltd (535217) Share Analysis – Quality, Growth & Valuation Zone & DeciZen Rating

Name: HPC Biosciences Ltd (535217)
Brand: HPC Biosciences

HPC Biosciences Ltd (535217)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 535217 NSE: Agriculture | Small Cap | HPC Biosciences Share Price

HPC Biosciences Ltd (535217)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 535217 NSE: Agriculture | Small Cap | HPC Biosciences Share Price

Key Metrics

Valuation Multiples

Market Cap

₹410 Cr.

Current Price

₹25.7

52-Week Low / High

₹26 / 26

TTM EPS

₹0

TTM Sales

₹0.2 Cr.

Book Value per Share

₹2.1

P/E Ratio

0.00

Industry PE

16.1

Price to Book (P/B)

12.48

In line with its 5-year historical median

Price to Sales (P/S)

1942.43

Higher than its 5-year historical median

EV/EBITDA

771.29

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

3.62%

Return on Capital Employed (ROCE)

3.69%

Return on Assets (ROA)

3.58%

Operating Profit Margin

70.8%

Net Profit Margin

51.16%

Gross Profit Margin

74.6%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

90.83%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

86.21%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

244.12%

Asset Quality

Promoter Holding

21.93%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹17 Cr.

Equity

₹16 Cr.

Face Value

₹1

All Time Low / High

₹3.73 / 75.75

HPC Biosciences stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	TTM
ROCE % ⓘ	125%	18.4%	4.5%	2.6%	1.7%	1.9%	0.8%	1.9%	1.1%	3.7%	-
Value Creation Index ⓘ	7.9	0.3	-0.7	-0.8	-0.9	-0.9	-0.9	-0.9	-0.9	-0.7	-
Growth Parameters ⓘ
Sales ⓘ	2.9	4.8	3.5	3.1	1.9	2.3	2	1.6	1.2	2.3	0
Sales YoY Gr.	-	64.1%	-27.3%	-10.7%	-39.5%	20.9%	-13.7%	-18%	-25%	90.8%	-
Adj EPS ⓘ	0.9	0.2	0.1	0	0	0	0	0	0	0.1	0
YoY Gr.	-	-78.2%	-57.9%	-50%	-25%	0%	-66.7%	200%	-33.3%	250%	-
BVPS (₹) ⓘ	1.4	1.7	1.8	1.8	1.9	1.9	1.9	2	2	2.1	2.1
Adj Net Profit ⓘ	3.1	3	1.2	0.7	0.5	0.5	0.2	0.6	0.3	1.2	0
Cash Flow from Ops. ⓘ	-0.4	3.4	4	0.2	-0.2	1.1	0.1	1.2	0.8	1.4	-
Debt/CF from Ops. ⓘ	0	0	0.1	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-2.6%	4.1%	5.5%	90.8%
Adj EPS ⓘ	-24.4%	18.5%	91.3%	250%
BVPSⓘ	4.6%	2%	2.2%	3.5%
Share Price	-4.6%	-0.2%	-0.7%	-

Key Financial Parameters ⓘ

	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	TTM
Return on Equity % ⓘ	125.8	18.3	4.4	2.4	1.5	1.7	0.6	1.8	1.1	3.6	0
Op. Profit Mgn % ⓘ	109.6	90.3	73.7	64.6	93.8	60.9	48.5	75.3	72.3	70.8	77.6
Net Profit Mgn % ⓘ	105.2	62.5	35.7	22.8	24.7	22.5	10.1	34.6	28.1	51.2	0
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	228	667	1,587	2,145	4,122	3,788	4,763	6,058	8,382	4,584	1,058
Cash Conv. Cycle ⓘ	71	125	156	205	701	778	1,049	1,398	1,887	996	1,038

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Sales	2.90	4.76	3.46	3.09	1.87	2.26	1.94	1.60	1.20	2.29
Operating Expenses ⓘ +	-0.28	0.46	0.91	1.09	0.12	0.88	1	0.39	0.33	0.67
Manufacturing Costs	0.13	0.23	0.24	0.15	0.25	0.33	0.30	0.14	0.08	0.20
Material Costs	-0.78	-0.26	0.22	0.40	-0.59	0.04	0.30	0.04	0.08	0.26
Employee Cost	0.24	0.27	0.20	0.22	0.21	0.25	0.21	0.10	0.09	0.05
Other Costs ⓘ	0.13	0.23	0.25	0.32	0.24	0.27	0.19	0.11	0.08	0.16
Operating Profit ⓘ	3.18	4.30	2.55	2	1.75	1.37	0.94	1.21	0.87	1.62
Operating Profit Margin (%)	109.6%	90.3%	73.7%	64.6%	93.8%	60.9%	48.5%	75.3%	72.3%	70.8%
Other Income ⓘ +	0	0.01	0.06	0.17	0.14	0.19	0.14	0.09	0.10	0.09
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0.01	0	0.01	0	0	0
Depreciation ⓘ	0.13	1.33	1.36	1.41	1.38	0.99	0.84	0.72	0.61	0.51
Profit Before Tax ⓘ	3.05	2.98	1.26	0.76	0.50	0.57	0.23	0.58	0.36	1.19
Tax ⓘ	0	0	0.02	0.05	0.04	0.06	0.03	0.02	0.02	0.02
Profit After Tax	3.05	2.98	1.24	0.71	0.46	0.51	0.20	0.55	0.34	1.17
PAT Margin (%)	105.2%	62.5%	35.7%	22.8%	24.7%	22.5%	10.1%	34.6%	28.1%	51.2%
Adjusted EPS (₹)	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of HPC Biosciences - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Equity and Liabilities
Shareholders Fund +	4.80	27.68	28.92	29.63	30.09	30.59	30.79	31.34	31.68	32.85
Share Capital ⓘ	1.75	15.96	15.96	15.96	15.96	15.96	15.96	15.96	15.96	15.96
Reserves ⓘ	3.05	11.72	12.96	13.67	14.13	14.63	14.83	15.38	15.72	16.89
Debt +	0	0.10	0.38	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0.10	0.38	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	0	0	0
Others Liabilities ⓘ	0	0.04	0.10	0.08	0.10	0.40	0.47	0.56	0.46	0.28
Total Liabilities ⓘ	4.80	27.83	29.40	29.70	30.19	31	31.26	31.90	32.14	33.13
Fixed Assets
Net Fixed Assets ⓘ +	1.10	10.57	9.53	8.12	6.74	5.75	4.91	4.19	3.58	3.07
Gross Block	1.23	12.03	12.35	12.35	12.35	12.35	12.35	12.35	12.35	12.35
Accumulated Depreciation	0.13	1.46	2.82	4.23	5.61	6.60	7.44	8.16	8.77	9.28
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	2.49	2.79	0.30	0.30	0.30	0.30	0.30	0.30	0.30
Inventories	0.78	1.04	0.82	0.67	1.26	1.22	0.92	0.88	0.80	0.55
Trade Receivables	0.35	1.09	0	1.98	3.26	3.88	5.16	5.29	5.42	5.70
Cash Equivalents	0.11	0.70	0.45	0.86	0.85	0.07	0.05	0.27	0.30	0.30
Others Assets ⓘ	2.46	11.94	15.81	17.77	17.78	19.77	19.92	20.97	21.73	23.21
Total Assets ⓘ	4.80	27.83	29.40	29.70	30.19	31	31.26	31.90	32.14	33.13

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Cash Flow From Operating Activity ⓘ +	-0.37	3.40	3.99	0.22	-0.18	1.09	0.08	1.17	0.82	1.36
PBT ⓘ	3.05	2.98	1.26	0.76	0.50	0.57	0.23	0.58	0.36	1.19
Adjustment ⓘ	0.13	1.38	1.40	1.36	1.36	0.92	0.77	0.64	0.51	0.43
Changes in Working Capital ⓘ	-3.55	-0.96	1.35	-1.89	-2.02	-0.38	-0.82	-0.05	-0.04	-0.26
Tax Paid ⓘ	0	0	-0	-0.01	-0.03	-0.02	-0.10	0	0	0
Cash Flow From Investing Activity ⓘ +	-1.20	-22.81	-4.53	0.67	0.17	-1.87	-0.10	-0.96	-0.79	0.06
Capex	-1.23	-10.80	-0.33	0	0	0	0	0	0	0
Net Investments	0.03	-2.49	-0.30	2.49	0	0	0	0	0	0
Others ⓘ	0	-9.53	-3.90	-1.82	0.17	-1.87	-0.10	-0.96	-0.79	0.06
Cash Flow From Financing Activity ⓘ +	1.67	20.01	0.28	-0.47	0	0	0	0	0	0
Net Proceeds from Shares ⓘ	1.70	19.91	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.03	0.10	0.28	-0.47	0	0	0	0	0	0
Net Cash Flow ⓘ	0.10	0.59	-0.25	0.42	-0.02	-0.77	-0.02	0.21	0.03	1.42

Financial Ratio

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Ratios
ROE (%)	125.8	18.47	4.41	2.44	1.56	1.68	0.64	1.78	1.07	3.62
ROCE (%)	124.95	18.43	4.45	2.6	1.73	1.88	0.78	1.86	1.14	3.69
Asset Turnover Ratio	1.19	0.29	0.12	0.1	0.06	0.07	0.06	0.05	0.04	0.07
PAT to CFO Conversion(x)	-0.12	1.14	3.22	0.31	-0.39	2.14	0.4	2.13	2.41	1.16
Working Capital Days
Receivable Days	43.80	55.20	0	233.60	512.40	577.10	848.10	1,192.40	1,630.40	888.10
Inventory Days	97.90	69.60	98.10	87.90	188.40	200.60	201.10	205.60	256.40	108
Payable Days	0	0	0	0	0	0	0	0	0	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

HPC Biosciences Ltd FAQs

The current trading price of HPC Biosciences on 29-Jul-2024 16:01 is ₹25.68.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Jul-2024 the market cap of HPC Biosciences stood at ₹409.9 Cr

The latest P/E ratio of HPC Biosciences as of 28-Jul-2024 is 0.00.

The latest P/B ratio of HPC Biosciences as of 28-Jul-2024 is 12.48.

The 52-week high of HPC Biosciences is ₹25.68 and the 52-week low is ₹25.68.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of HPC Biosciences is ₹0.21 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that HPC Biosciences Ltd is a average quality company.

The key valuation ratios of HPC Biosciences Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

No data found

About HPC Biosciences Ltd

No data to display

HPC Biosciences Ltd (535217)

HPC Biosciences Ltd (535217)

HPC Biosciences stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of HPC Biosciences - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

HPC Biosciences Ltd FAQs

About HPC Biosciences Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

HPC Biosciences Ltd (535217)

HPC Biosciences Ltd (535217)

HPC Biosciences stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of HPC Biosciences - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

HPC Biosciences Ltd FAQs

What is the share price of HPC Biosciences?

What is the market cap of HPC Biosciences?

What is the P/E ratio of HPC Biosciences?

What is the P/B ratio of HPC Biosciences?

What is the 52-week high and low of HPC Biosciences?

What is the TTM revenue of HPC Biosciences?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About HPC Biosciences Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.